Martha Morrell - Jun 4, 2021 Form 4/A - Amendment Insider Report for NeuroPace Inc (NPCE)

Role
Chief Medical officer
Signature
/s/ Mark B. Weeks, Attorney-in-Fact
Stock symbol
NPCE
Transactions as of
Jun 4, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
6/29/2021, 06:12 PM
Date Of Original Report
Jun 8, 2021
Next filing
Mar 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NPCE Common Stock Award $0 +8.31K +547.43% $0.00 9.83K Jun 4, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NPCE Stock Option (Right to Buy) Award $0 +16.6K $0.00 16.6K Jun 4, 2021 Common Stock 16.6K $21.67 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on April 22, 2022 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.
F2 25% of the shares subject to the option vest on April 22, 2022. The remaining shares subject to the option vest in twelve (12) equal quarterly installments thereafter. The option is early exercisable.

Remarks:

This amendment to Form 4 is being filed to correct (a) the amount of RSUs acquired and the amount of securities shares beneficially owned directly by the Reporting Person following the transaction in Table I, and (b) the amount of options acquired and the amount of options of this class beneficially owned directly by the Reporting Person following the transaction in Table II.